Trial of Tocilizumab in Giant-Cell Arteritis
Volume: 377, Issue: 4, Pages: 317 - 328
Published: Jul 27, 2017
Abstract
Giant-cell arteritis commonly relapses when glucocorticoids are tapered, and the prolonged use of glucocorticoids is associated with side effects. The effect of the interleukin-6 receptor alpha inhibitor tocilizumab on the rates of relapse during glucocorticoid tapering was studied in patients with giant-cell...
Paper Details
Title
Trial of Tocilizumab in Giant-Cell Arteritis
Published Date
Jul 27, 2017
Volume
377
Issue
4
Pages
317 - 328
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History